Dr. Allison Rosenthal, Assistant Professor of Medicine and a driving force behind Mayo Clinic’s Adolescent and Young Adult Cancer Program, candidly shares her personal odyssey as a leukemia survivor during her young adulthood and how this transformative experience steered her career toward advocating for AYA cancer patients. She navigates through complex topics such as survivor guilt, identifying when survivorship begins in the patient journey, and the crucial decision-making between pediatric and adult specialists based on patient age. Dr. Rosenthal also sheds light on the indispensable role of financial counseling and support services for AYA patients while unraveling ongoing research endeavors in this setting.
N/A
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
